Survodutide

Weight Loss

7Vendors

Dual GLP-1/glucagon agonist gaining attention for substantial weight loss and metabolic improvement. It is mainly pursued by users looking for next-generation obesity tools beyond standard GLP-1s.

Studies
Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis.	PubMed
Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves blood pressure in adults with obesity: A post hoc analysis from a randomized, placebo-controlled, dose-finding, phase 2 trial.	PubMed
BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy.	PubMed

Survodutide Vendors
EZ Peptides 0.0	Profile
Flawless Compounds 0.0	Profile
Glow Aminos 0.0	Profile
Orbitrex Peptides 0.0	Profile
Peptidology 0.0	Profile
Peptira 0.0	Profile
Tydes 0.0	Profile